Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects
Clinical trial NCT01873339 · COMPLETED
Trial details
- NCT number
- NCT01873339
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-19
- Primary completion
- 2013-09-12
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.